Chen, X
Hansen L, Deacon CF, Orskov C, and Holst JJ
Non-pharmacological interventions (weight loss 7-10%, Mediterranean diet, and physical activity) are represented as the therapeutic basis, together with pharmacological strategies under investigation or clinical use (THR- agonists, FGF-21 analogs, pan-PPAR modulators, GLP-1 RAs, GLP-1/GIP, SGLT-2 inhibitors, metformin, and statins)
These external validation findings further support the potential negative causal relationship between ILC and SZ
Dconseill aux femmes enceintes ou allaitant leur enfant
Syed prescribes and manages semaglutide under full medical supervision, ensuring each patient receives the right dosage, proper monitoring, and comprehensive support throughout treatment